Статті в журналах з теми "ABCB1 inhibitors"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "ABCB1 inhibitors".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Michaelis, Martin, Florian Rothweiler, Thomas Nerreter, Marijke Van Rikxoort, Mohsen Sharifi, Michael Wiese, Taravat Ghafourian, and Jindrich Cinatl. "Differential Effects of the Oncogenic BRAF Inhibitor PLX4032 (Vemurafenib) and its Progenitor PLX4720 on ABCB1 Function." Journal of Pharmacy & Pharmaceutical Sciences 17, no. 1 (April 6, 2014): 154. http://dx.doi.org/10.18433/j3tw24.
Повний текст джерелаMichaelis, Martin, Yvonne Voges, Florian Rothweiler, Fabian Weipert, Amara Zia-Ahmad, Jaroslav Cinatl, Andreas von Deimling, et al. "Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines." Cancers 12, no. 3 (March 2, 2020): 577. http://dx.doi.org/10.3390/cancers12030577.
Повний текст джерелаMichaelis, Martin, Florian Rothweiler, Thomas Nerreter, Mohsen Sharifi, Taravat Ghafourian, and Jindrich Cinatl. "Karanjin interferes with ABCB1, ABCC1, and ABCG2." Journal of Pharmacy & Pharmaceutical Sciences 17, no. 1 (March 10, 2014): 92. http://dx.doi.org/10.18433/j3bw2s.
Повний текст джерелаYin, Wei, Jianfeng Xu, and Yanjiao Mao. "Synergistic effects of autophagy inhibitors combined with cisplatin against cisplatin-resistant nasopharyngeal cancer cells." Biochemistry and Cell Biology 99, no. 3 (June 2021): 322–29. http://dx.doi.org/10.1139/bcb-2020-0283.
Повний текст джерелаIbrahim, Mahmoud A. A., Khlood A. A. Abdeljawaad, Alaa H. M. Abdelrahman, Laila A. Jaragh-Alhadad, Hesham Farouk Oraby, Eslam B. Elkaeed, Gamal A. H. Mekhemer, et al. "Exploring Natural Product Activity and Species Source Candidates for Hunting ABCB1 Transporter Inhibitors: An In Silico Drug Discovery Study." Molecules 27, no. 10 (May 12, 2022): 3104. http://dx.doi.org/10.3390/molecules27103104.
Повний текст джерелаNatarajan, Karthika, Jasjeet Bhullar, Suneet Shukla, Mehmet Burcu, Suresh V. Ambudkar, and Maria R. Baer. "The Pim Kinase Inhibitor SGI-1776 Chemosensitizes Multidrug Resistant Cells by Both Inhibiting Drug Transport by ABCB1 and ABCG2 and Decreasing ABCB1 and ABCG2 Surface Expression On Cells That Overexpress Pim-1." Blood 120, no. 21 (November 16, 2012): 2462. http://dx.doi.org/10.1182/blood.v120.21.2462.2462.
Повний текст джерелаNosol, Kamil, Ksenija Romane, Rossitza N. Irobalieva, Amer Alam, Julia Kowal, Naoya Fujita, and Kaspar P. Locher. "Cryo-EM structures reveal distinct mechanisms of inhibition of the human multidrug transporter ABCB1." Proceedings of the National Academy of Sciences 117, no. 42 (October 5, 2020): 26245–53. http://dx.doi.org/10.1073/pnas.2010264117.
Повний текст джерелаWinter, Stuart S., Debbie M. Lovato, Hadya M. Khawaja, Bruce S. Edwards, Irena D. Steele, Susan M. Young, Tudor I. Oprea, Larry A. Sklar, and Richard S. Larson. "Identification of Off-Patent Drugs That Reverse Daunorubicin Efflux Mediated by ABCB1 in T-ALL Cells." Blood 108, no. 11 (November 16, 2006): 2603. http://dx.doi.org/10.1182/blood.v108.11.2603.2603.
Повний текст джерелаWang, Jingqiu, Dong-Hua Yang, Yuqi Yang, Jing-Quan Wang, Chao-Yun Cai, Zi-Ning Lei, Qiu-Xu Teng, Zhuo-Xun Wu, Linguo Zhao, and Zhe-Sheng Chen. "Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells." International Journal of Molecular Sciences 21, no. 4 (February 19, 2020): 1387. http://dx.doi.org/10.3390/ijms21041387.
Повний текст джерелаDohse, Marius, Robert W. Robey, Cornelia Brendel, Susan Bates, Andreas Neubauer, and Christian Scharenberg. "Efflux of the Tyrosine Kinase Inhibitors Imatinib and Nilotinib (AMN107) Is Mediated by ABCB1 (MDR1)-Type P-Glycoprotein." Blood 108, no. 11 (November 16, 2006): 1367. http://dx.doi.org/10.1182/blood.v108.11.1367.1367.
Повний текст джерелаDavies, Andrea, Athina Giannoudis, Claire M. Lucas, Robert J. Harris, Paul W. Manley, Munir Pirmohamed, and Richard E. Clark. "Characterisation of Nilotinib Transport in Chronic Myeloid Leukaemia Cells." Blood 110, no. 11 (November 16, 2007): 2364. http://dx.doi.org/10.1182/blood.v110.11.2364.2364.
Повний текст джерелаvan Tellingen, Olaf, Mark C. de Gooijer, Stefanie Zuidema, Amber Meurs, Ceren H. Çitirikkaya, Nikkie Venekamp, and Jos H. Beijnen. "EXTH-72. CONTINUOUS INFUSION STUDIES REVEAL THE POTENCY OF ELACRIDAR TO ACT AS A PHARMACO-ENHANCER FOR TREATMENT OF INTRACRANIAL DISEASES BY INHIBITING ABCB1 AND ABCG2 AT THE BLOOD-BRAIN BARRIER." Neuro-Oncology 22, Supplement_2 (November 2020): ii103. http://dx.doi.org/10.1093/neuonc/noaa215.426.
Повний текст джерелаWenzel, Tim, Thomas Büch, Nicole Urban, Ulrike Weirauch, Katrin Schierle, Achim Aigner, Michael Schaefer, and Hermann Kalwa. "Restoration of MARCK enhances chemosensitivity in cancer." Journal of Cancer Research and Clinical Oncology 146, no. 4 (February 13, 2020): 843–58. http://dx.doi.org/10.1007/s00432-020-03149-2.
Повний текст джерелаSorf, Ales, Simona Sucha, Anselm Morell, Eva Novotna, Frantisek Staud, Alzbeta Zavrelova, Benjamin Visek, Vladimir Wsol, and Martina Ceckova. "Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors." Cancers 12, no. 6 (June 16, 2020): 1596. http://dx.doi.org/10.3390/cancers12061596.
Повний текст джерелаLinke, Dinah, Lukas Donix, Claudia Peitzsch, Holger H. H. Erb, Anna Dubrovska, Manuel Pfeifer, Christian Thomas, Susanne Fuessel, and Kati Erdmann. "Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines." International Journal of Molecular Sciences 24, no. 1 (December 30, 2022): 666. http://dx.doi.org/10.3390/ijms24010666.
Повний текст джерелаHuličiak, Martin, Ivan Vokřál, Ondřej Holas, Ondřej Martinec, František Štaud, and Lukáš Červený. "Evaluation of the Potency of Anti-HIV and Anti-HCV Drugs to Inhibit P-Glycoprotein Mediated Efflux of Digoxin in Caco-2 Cell Line and Human Precision-Cut Intestinal Slices." Pharmaceuticals 15, no. 2 (February 18, 2022): 242. http://dx.doi.org/10.3390/ph15020242.
Повний текст джерелаMakrecka-Kuka, Marina, Jelena Vasiljeva, Pavels Dimitrijevs, and Pavel Arsenyan. "Olaparib Conjugates with Selenopheno[3,2-c]quinolinone Inhibit PARP1 and Reverse ABCB1-Related Multidrug Resistance." Pharmaceutics 14, no. 12 (November 23, 2022): 2571. http://dx.doi.org/10.3390/pharmaceutics14122571.
Повний текст джерелаMcCorkle, J. Robert, Justin W. Gorski, Jinpeng Liu, McKayla B. Riggs, Anthony B. McDowell, Nan Lin, Chi Wang, Frederick R. Ueland, and Jill M. Kolesar. "Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer." PLOS ONE 16, no. 8 (August 4, 2021): e0254205. http://dx.doi.org/10.1371/journal.pone.0254205.
Повний текст джерелаIvnitski-Steele, Irena, Richard S. Larson, Debbie M. Lovato, Hadya M. Khawaja, Stuart S. Winter, Tudor I. Oprea, Larry A. Sklar, and Bruce S. Edwards. "High-Throughput Flow Cytometry to Detect Selective Inhibitors of ABCB1, ABCC1, and ABCG2 Transporters." ASSAY and Drug Development Technologies 6, no. 2 (April 2008): 263–76. http://dx.doi.org/10.1089/adt.2007.107.
Повний текст джерелаPajeva, Ilza K, Christoph Globisch, and Michael Wiese. "Combined Pharmacophore Modeling, Docking, and 3D QSAR Studies of ABCB1 and ABCC1 Transporter Inhibitors." ChemMedChem 4, no. 11 (November 2, 2009): 1883–96. http://dx.doi.org/10.1002/cmdc.200900282.
Повний текст джерелаVasiljeva, Jelena, Marina Makrecka-Kuka, Ilona Domracheva, Karlis Vilks, Pavels Dimitrijevs, and Pavel Arsenyan. "Development of prospective non-toxic inhibitors of ABCB1 activity and expression in a series of selenophenoquinolinones." New Journal of Chemistry 46, no. 16 (2022): 7424–32. http://dx.doi.org/10.1039/d2nj00340f.
Повний текст джерелаGiannoudis, Athina, Andrea Davies, Claire M. Lucas, Robert J. Harris, Munir Pirmohamed, and Richard E. Clark. "Effective dasatinib uptake may occur without human organic cation transporter 1 (hOCT1): implications for the treatment of imatinib-resistant chronic myeloid leukemia." Blood 112, no. 8 (October 15, 2008): 3348–54. http://dx.doi.org/10.1182/blood-2007-10-116236.
Повний текст джерелаMoss, Darren M., Wai San Kwan, Neill J. Liptrott, Darren L. Smith, Marco Siccardi, Saye H. Khoo, David J. Back, and Andrew Owen. "Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir." Antimicrobial Agents and Chemotherapy 55, no. 2 (November 15, 2010): 879–87. http://dx.doi.org/10.1128/aac.00623-10.
Повний текст джерелаSava, Georgina P., Hailing Fan, Rosemary A. Fisher, Sabrina Lusvarghi, Sunil Pancholi, Suresh V. Ambudkar, Lesley-Ann Martin, R. Charles Coombes, Lakjaya Buluwela, and Simak Ali. "ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942." Oncogene 39, no. 3 (September 17, 2019): 651–63. http://dx.doi.org/10.1038/s41388-019-1008-y.
Повний текст джерелаSilbermann, Katja, Jiyang Li, Vigneshwaran Namasivayam, Fabian Baltes, Gerd Bendas, Sven Marcel Stefan, and Michael Wiese. "Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists." Journal of Medicinal Chemistry 63, no. 18 (July 31, 2020): 10412–32. http://dx.doi.org/10.1021/acs.jmedchem.0c00961.
Повний текст джерелаTamaki, Akina, Caterina Ierano, Gergely Szakacs, Robert W. Robey, and Susan E. Bates. "The controversial role of ABC transporters in clinical oncology." Essays in Biochemistry 50 (September 7, 2011): 209–32. http://dx.doi.org/10.1042/bse0500209.
Повний текст джерелаOnafuye, Hannah, Sebastian Pieper, Dennis Mulac, Jindrich Cinatl Jr., Mark N. Wass, Klaus Langer, and Martin Michaelis. "Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells." Beilstein Journal of Nanotechnology 10 (August 14, 2019): 1707–15. http://dx.doi.org/10.3762/bjnano.10.166.
Повний текст джерелаÖzenver, Nadire, Joelle C. Boulos, and Thomas Efferth. "Activity of Cordycepin From Cordyceps sinensis Against Drug-Resistant Tumor Cells as Determined by Gene Expression and Drug Sensitivity Profiling." Natural Product Communications 16, no. 2 (February 2021): 1934578X2199335. http://dx.doi.org/10.1177/1934578x21993350.
Повний текст джерелаKochanek, Stanton J., David A. Close, Allen Xinwei Wang, Tongying Shun, Philip E. Empey, Julie L. Eiseman, and Paul A. Johnston. "Confirmation of Selected Synergistic Cancer Drug Combinations Identified in an HTS Campaign and Exploration of Drug Efflux Transporter Contributions to the Mode of Synergy." SLAS DISCOVERY: Advancing the Science of Drug Discovery 24, no. 6 (April 30, 2019): 653–68. http://dx.doi.org/10.1177/2472555219844566.
Повний текст джерелаFedina, L. V., I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, and D. A. Sychev. "Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis." Rational Pharmacotherapy in Cardiology 18, no. 6 (January 6, 2023): 624–29. http://dx.doi.org/10.20996/1819-6446-2022-12-02.
Повний текст джерелаEadie, Laura N., Verity A. Saunders, Tamara M. Leclercq, Susan Branford, Deborah L. White, and Timothy P. Hughes. "The Allosteric Inhibitor ABL001 Is Susceptible to Resistance in Vitro Mediated By Overexpression of the Drug Efflux Transporters ABCB1 and ABCG2." Blood 126, no. 23 (December 3, 2015): 4841. http://dx.doi.org/10.1182/blood.v126.23.4841.4841.
Повний текст джерелаLiu, Hongming, Zhiguo Ma, and Baojian Wu. "Structure-activity relationships andin silicomodels of P-glycoprotein (ABCB1) inhibitors." Xenobiotica 43, no. 11 (April 25, 2013): 1018–26. http://dx.doi.org/10.3109/00498254.2013.791003.
Повний текст джерелаHilgeroth, Andreas, Marc Hemmer, Sebastian Neuber, Josef Molnar, and Hermann Lage. "Discovery of 9,10-Dihydroacridines as Novel Class of ABCB1 Inhibitors." Medicinal Chemistry 11, no. 4 (April 29, 2015): 329–35. http://dx.doi.org/10.2174/1573406410666141111100720.
Повний текст джерелаvon Richter, Oliver, Hristos Glavinas, Peter Krajcsi, Stephanie Liehner, Beate Siewert, and Karl Zech. "A novel screening strategy to identify ABCB1 substrates and inhibitors." Naunyn-Schmiedeberg's Archives of Pharmacology 379, no. 1 (August 29, 2008): 11–26. http://dx.doi.org/10.1007/s00210-008-0345-0.
Повний текст джерелаHuang, Ying, Paul E. Blower, Ruqing Liu, Zunyan Dai, Anh-Nhan Pham, Hojin Moon, Jialong Fang, and Wolfgang Sadée. "Chemogenomic Analysis Identifies Geldanamycins as Substrates and Inhibitors of ABCB1." Pharmaceutical Research 24, no. 9 (April 25, 2007): 1702–12. http://dx.doi.org/10.1007/s11095-007-9300-x.
Повний текст джерелаHiwase, Devendra K., Jane Engler, Verity Saunders, Deborah L. White, and Timothy Hughes. "In Contrast to Imatinib, Dasatinib Intracellular Concentration In CML-CD34+ Progenitors Is Not Significantly Different Than That Observed In CD34- Mature Cells." Blood 116, no. 21 (November 19, 2010): 1205. http://dx.doi.org/10.1182/blood.v116.21.1205.1205.
Повний текст джерелаWhite, Deborah L., Liu Lu, Timothy P. Clackson, Verity A. Saunders, and Timothy P. Hughes. "ATP Dependent Efflux Transporters ABCB1 and ABCG2 Are Unlikely to Impact the Efficacy, or Mediate Resistance to the Tyrosine Kinase Inhibitor, Ponatinib." Blood 118, no. 21 (November 18, 2011): 2745. http://dx.doi.org/10.1182/blood.v118.21.2745.2745.
Повний текст джерелаEadie, Laura, Timothy P. Hughes, and Deborah L. White. "Increasing Expression Of The Efflux Transporter ABCB1 May Predispose CML Cells To Overt TKI Resistance." Blood 122, no. 21 (November 15, 2013): 5157. http://dx.doi.org/10.1182/blood.v122.21.5157.5157.
Повний текст джерелаAdorni, Maria Pia, Maricla Galetti, Silvia La Monica, Matteo Incerti, Alessandro Ruffoni, Lisa Elviri, Ilaria Zanotti, et al. "A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC." International Journal of Molecular Sciences 24, no. 2 (January 4, 2023): 989. http://dx.doi.org/10.3390/ijms24020989.
Повний текст джерелаHiwase, Devendra K., Deborah L. White, Verity A. Saunders, Phuong Dang, Amity Venables, Laura Eadie, Steph Zrim, L. Bik To, Junia V. Melo, and Timothy P. Hughes. "In Contrast to Imatinib, OCT-1 Mediated Influx Has Minimal Impact on Cellular Uptake of Dasatinib in CML Patients at Diagnosis." Blood 110, no. 11 (November 16, 2007): 1937. http://dx.doi.org/10.1182/blood.v110.11.1937.1937.
Повний текст джерелаSambyalova, A. Yu, T. A. Bairova, T. L. Manaenkova, A. V. Belskikh, E. V. Belyaeva, O. A. Ershova, D. V. Kumratov, et al. "Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study." Acta Biomedica Scientifica 7, no. 5-1 (December 6, 2022): 53–61. http://dx.doi.org/10.29413/abs.2022-7.5-1.7.
Повний текст джерелаGiannoudis, Athina, Andrea Davies, Claire M. Lucas, Robert J. Harris, Munir Pirmohamed, and Richard E. Clark. "Unlike Imatinib, Dasatinib Uptake into Chronic Myeloid Leukaemia Cells Is Independent of hOCT1 Expression." Blood 110, no. 11 (November 16, 2007): 3458. http://dx.doi.org/10.1182/blood.v110.11.3458.3458.
Повний текст джерелаDeng, Minjuan, Kang Qin, Yang Li, Yu Jiang, Wei Jin, and Zhirong Shen. "Abstract 5338: Pamiparib as a non-P-glycoprotein substrate PARP inhibitor can overcome ABCB1-mediated multidrug resistance in ovarian cancer cells." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5338. http://dx.doi.org/10.1158/1538-7445.am2022-5338.
Повний текст джерелаZhang, Sheng-lie, Yin-xiang Wei, Qian Li, Hao-peng Sun, Hui Peng, and Qi-dong You. "Pharmacophore-Based Drug Design and Biological Evaluation of Novel ABCB1 Inhibitors." Chemical Biology & Drug Design 81, no. 3 (December 26, 2012): 349–58. http://dx.doi.org/10.1111/cbdd.12081.
Повний текст джерелаDastvan, Reza, Smriti Mishra, Yelena B. Peskova, Robert K. Nakamoto, and Hassane S. Mchaourab. "Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors." Science 364, no. 6441 (May 16, 2019): 689–92. http://dx.doi.org/10.1126/science.aav9406.
Повний текст джерелаYakusheva, Elena N., Aleksey V. Shchulkin, Ivan V. Chernykh, Natalia M. Popova, Anna A. Kotlyarova, and Alexandr A. Slepnev. "Assessment of drugs belonging to inhibitors and inductors of p-glycoprotein in vitro." Reviews on Clinical Pharmacology and Drug Therapy 17, no. 1 (May 30, 2019): 71–78. http://dx.doi.org/10.17816/rcf17171-78.
Повний текст джерелаChernykh, Ivan V., Alexey V. Shchulkin, Natalya M. Popova, Ekaterina E. Kirichenko, and Elena N. Yakusheva. "Vegetative polysaccharides: new target and direction of clinical use." Reviews on Clinical Pharmacology and Drug Therapy 16, no. 4 (December 15, 2018): 5–9. http://dx.doi.org/10.17816/rcf1645-9.
Повний текст джерелаLentz, Fabian, Norbert Reiling, Gabriella Spengler, Annamária Kincses, Andrea Csonka, Joseph Molnár, and Andreas Hilgeroth. "Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of Clofazimine." Molecules 24, no. 16 (August 8, 2019): 2873. http://dx.doi.org/10.3390/molecules24162873.
Повний текст джерелаMicucci, Matteo, Maurizio Viale, Alberto Chiarini, Domenico Spinelli, Maria Frosini, Cinzia Tavani, Massimo Maccagno, Lara Bianchi, Rosaria Gangemi, and Roberta Budriesi. "3-Aryl-4-nitrobenzothiochromans S,S-dioxide: From Calcium-Channel Modulators Properties to Multidrug-Resistance Reverting Activity." Molecules 25, no. 5 (February 27, 2020): 1056. http://dx.doi.org/10.3390/molecules25051056.
Повний текст джерелаTsai, Yo-Ting, Gerard Lozanski, Amy M. Lehman, Ellen Sass, Erin K. Hertlein, Santosh Salunke, Ching-Shih Chen, Michael R. Grever, John C. Byrd, and David M. Lucas. "BRAFV600E Induces ABCB1/P-Glycoprotein Expression and Drug Resistance in B-Cells Via AP-1 Activation." Blood 126, no. 23 (December 3, 2015): 2477. http://dx.doi.org/10.1182/blood.v126.23.2477.2477.
Повний текст джерела